TSX closed
Loading markets…

Advertisement

Stocks

What's Going On With Pharmacielo Ltd Stock Thursday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:PCLO.V

Follow PCLO

Photos provided by Pexels

Pharmacielo Ltd's stock has seen a notable uptick this week despite a lack of significant news.

Pharmacielo Ltd (PCLO.V) has experienced a weekly increase of 9.09%, closing at C$0.06. This movement comes amid limited company-specific news, prompting investors to examine the technical indicators and market conditions surrounding the stock.

Advertisement

Pharmacielo Ltd

PCLO.V

Full stock page →

PCLO.V

Pharmacielo Ltd

Source:WealthAwesomeWealthAwesome
↑ $0.00 (0.00%)
120 day period
$0.04$0.08$0.11Mar 2Jun 15Oct 7

Market cap

$13.26M

52W high

$0.17

52W low

$0.04

1W change

+9.09%

Beta

0.62

Analyst Price Targets

Based on analyst covering PCLO · as of Sep 17, 2026

📈

Wall Street analysts forecast PCLO stock price to rise 4066.7% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$2.50

+4066.7% Upside

Current Price

C$0.06

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on PCLO's historical volatility

HistoricalForecast68%95%
C$0.01C$0.07C$0.12C$0.18C$0.24C$0.29TodayApr 24Jul 16Oct 7Nov 19Jan 2Feb 14

30-Day Vol

145.5%

Annualized

90-Day Vol

176.9%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.05

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.06C$0.03 – C$0.09
60 trading daysC$0.05C$0.03 – C$0.11
90 trading daysC$0.05C$0.02 – C$0.12

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: While Pharmacielo's stock has shown some positive movement this week, investors should remain cautious, given the company's ongoing challenges in profitability and market performance. The technical indicators suggest a stable short-term outlook, but the long-term picture remains uncertain.

9.09% Weekly Increase

Despite the positive weekly performance, the stock remains down 55.56% year-to-date, highlighting ongoing volatility.

Bull case

Analysts are optimistic about Pharmacielo’s future, suggesting a potential upside with an average target of C$2.50. If the company can stabilize its operations and improve its financial metrics, investors could see significant returns.

Bear case

However, the company's negative profit margins and a significant decline in year-to-date performance (-55.56%) indicate that investors should be cautious about the risks associated with investing in Pharmacielo at this time.

Weekly Price Action

Pharmacielo Ltd (PCLO.V) has recorded a notable weekly increase of 9.09%, closing at C$0.06. This rise comes despite the absence of significant company news or developments, suggesting that investors may be reacting to broader market conditions or technical factors.

Technical Picture

Advertisement

The current technical indicators present a mixed picture for Pharmacielo. The stock is trading just above its 50-day moving average of C$0.06 (+0.3% vs price) but remains below its 200-day moving average of C$0.07 (-10.4% vs price). The 52-week range for the stock is C$0.04 to C$0.17, with the current price representing approximately 19% of that range. The stock has a beta of 0.62, indicating lower volatility compared to the market. Additionally, the latest trading volume of 748,000 shares significantly exceeds the 20-day average volume of 61,335 shares, suggesting increased interest from investors.

Market Fundamentals

Pharmacielo Ltd has a market capitalization of approximately C$13.26 million. The company's profit margin stands at a concerning -103.1%, and its return on equity (ROE) is -3013.2%. The earnings per share (EPS) for the trailing twelve months (TTM) is -0.02, reflecting ongoing financial challenges. Investors should consider these fundamentals when evaluating the stock's potential.

Analyst Outlook

Despite the current challenges, analysts maintain a bullish outlook for Pharmacielo Ltd, with an average target price of C$2.50. This implies a potential upside of approximately 4066.7% from the current price. However, investors should remain cautious and consider the company's financial struggles before making investment decisions.

Price Action Summary

Pharmacielo Ltd closed at C$0.06, reflecting a 0.00% change on the day. The stock's performance this week, along with its technical indicators, suggests a cautious approach for investors considering exposure to the health care sector.


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: October 9, 2026
Last Updated: October 9, 2026

Core portfolio

Awesome Portfolio™

14.8% a year since 2017, against 9.7% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+14.8%

Awesome Portfolio™

+9.7%

S&P/TSX

+5.0 pp better a year

Total return

+254%

Awesome Portfolio™

+134%

S&P/TSX

+119 pp better than the TSX

2017-07-31 to 2026-09-29, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-29
-11.7%42.5%96.7%150.9%205.1%259.3%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement